<instructions>Your goal is to analyze the following comment and estimate how highly it will be upvoted by the Hacker News community.</instructions><comment><author>TheBeardKing</author><text>Since this drug was developed on public funding in the UK, how does that affect its pricing and incorporation in the NHS? I assume whoever gets the license to sell it in the US will have exclusivity and make it expensive as hell.&lt;p&gt;edit: Never mind, although the research took place at the University of London, it was funded by Ionis Pharmaceuticals (US) and further by Roche (Swiss multinational). The Guardian article relegates that bit of info to the very last line, as if they were just a minor part of the effort.
&lt;a href=&quot;http:&amp;#x2F;&amp;#x2F;markets.businessinsider.com&amp;#x2F;news&amp;#x2F;stocks&amp;#x2F;Ionis-Pharmaceuticals-Licenses-IONIS-HTT-Rx-to-Partner-Following-Successful-Phase-1-2a-Study-in-Patients-with-Huntington-s-Disease-1010933822&quot; rel=&quot;nofollow&quot;&gt;http:&amp;#x2F;&amp;#x2F;markets.businessinsider.com&amp;#x2F;news&amp;#x2F;stocks&amp;#x2F;Ionis-Pharmac...&lt;/a&gt;</text><parent_chain></parent_chain></comment><story><title>Defect that causes Huntington&apos;s disease has been corrected for the first time</title><url>http://www.bbc.com/news/health-42308341</url></story>
<instructions>Your goal is to analyze the following comment and estimate how highly it will be upvoted by the Hacker News community.</instructions><comment><author>Merem</author><text>Great news. Although it&amp;#x27;s already too late for my mother, my sister can definitely profit from it if it turns out well. And I guess I will have to take the test now to see whether I have the disease as well...</text><parent_chain></parent_chain></comment><story><title>Defect that causes Huntington&apos;s disease has been corrected for the first time</title><url>http://www.bbc.com/news/health-42308341</url></story>